New Technologies toward Dendritic Cell‐Based Cancer Immunotherapies

E-ISSN： 1346-8138|26|11|757-763

ISSN： 0385-2407

Source： THE JOURNAL OF DERMATOLOGY, Vol.26, Iss.11, 1999-11, pp. : 757-763

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dendritic Cell-Based Immunoregulatory Strategies

International Archives of Allergy and Immunology, Vol. 127, Iss. 4, 2002-05 ,pp. : 251-258

Karger

Access to resources Recommend Favorite

Dendritic Cell-Based Immunotherapy of Renal Cell Carcinoma

Urologia Internationalis, Vol. 61, Iss. 2, 1999-01 ,pp. : 67-71

Karger

Access to resources Recommend Favorite

Current Status of Dendritic Cell-Based Tumor Vaccination

Oncology Research and Treatment, Vol. 23, Iss. 6, 2001-01 ,pp. : 544-551

Karger

Access to resources Recommend Favorite

Low Noncytotoxic Concentrations of 5-Fluorouracil Have No Adverse Effects on Maturation and Function of Bone Marrow-Derived Dendritic Cells in vitro: A Potentially Safe Adjuvant for Dendritic Cell-Based Cancer Therapy

International Archives of Allergy and Immunology, Vol. 168, Iss. 2, 2015-0 ,pp. : 122-130

Karger

Access to resources Recommend Favorite

Stem cell clinical trials: toward cell-based therapy for retinal degenerations

By Klassen Henry

Clinical Investigation, Vol. 3, Iss. 8, 2013-08 ,pp. : 703-705

Future Science

Access to resources Recommend Favorite